News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
210 Results
Type
Article (9)
Press Release (201)
Section
Business (72)
Deals (18)
Drug Development (5)
FDA (12)
Job Trends (2)
News (98)
Policy (4)
Tag
Alliances (7)
Approvals (13)
Best Places to Work (2)
Clinical research (2)
COVID-19 (1)
Data (2)
Depression (5)
Diagnostics (1)
Earnings (44)
Events (35)
FDA (16)
Funding (3)
GLP-1 (1)
Government (1)
Guidances (1)
Healthcare (5)
Infectious disease (1)
IPO (18)
Legal (1)
Medical device (67)
Medtech (67)
Neuropsychiatric disorders (1)
Neuroscience (5)
NextGen: Class of 2026 (1)
Pain (1)
People (22)
Phase 1 (1)
Phase 2 (2)
Phase 3 (2)
Preclinical (1)
Regulatory (5)
Startups (1)
Date
Last 30 days (1)
Last 365 days (10)
2026 (1)
2025 (9)
2024 (11)
2023 (21)
2022 (33)
2021 (33)
2020 (32)
2019 (13)
2018 (7)
2017 (7)
2016 (3)
2015 (6)
2014 (8)
2013 (5)
2012 (10)
2011 (10)
Location
Asia (145)
Europe (9)
Massachusetts (14)
Pennsylvania (1)
United States (15)
210 Results for "brainsway".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)
January 12, 2026
·
6 min read
Press Releases
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
November 13, 2025
·
7 min read
Press Releases
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder
November 5, 2025
·
6 min read
Press Releases
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
September 17, 2025
·
7 min read
Press Releases
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
June 4, 2025
·
6 min read
Press Releases
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
May 14, 2025
·
13 min read
Press Releases
BrainsWay to Report First Quarter 2025 Financial Results on May 13, 2025
April 30, 2025
·
1 min read
Press Releases
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
June 12, 2025
·
6 min read
Press Releases
BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 4, 2025
·
1 min read
Business
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
BrainsWay Ltd., a world leader in advanced and non-invasive treatment for brain disorders, reported first quarter 2024 financial results and provided an operational update.
May 8, 2024
·
13 min read
1 of 21
Next
